Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Current Assets (2016 - 2026)

Angiodynamics' Current Assets history spans 16 years, with the latest figure at $155.6 million for Q1 2026.

  • For Q1 2026, Current Assets fell 9.71% year-over-year to $155.6 million; the TTM value through Feb 2026 reached $155.6 million, down 9.71%, while the annual FY2025 figure was $168.3 million, 12.9% down from the prior year.
  • Current Assets reached $155.6 million in Q1 2026 per ANGO's latest filing, down from $161.3 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $196.9 million in Q1 2024 to a low of $127.7 million in Q1 2022.
  • Average Current Assets over 5 years is $165.3 million, with a median of $163.5 million recorded in 2023.
  • Peak YoY movement for Current Assets: rose 29.06% in 2024, then dropped 12.9% in 2025.
  • A 5-year view of Current Assets shows it stood at $158.8 million in 2022, then rose by 16.77% to $185.5 million in 2023, then fell by 5.45% to $175.4 million in 2024, then decreased by 7.99% to $161.3 million in 2025, then decreased by 3.59% to $155.6 million in 2026.
  • Per Business Quant, the three most recent readings for ANGO's Current Assets are $155.6 million (Q1 2026), $161.3 million (Q4 2025), and $156.7 million (Q3 2025).